Promoter (genetics)
- Cannabis as a Gateway Drug for Opioid Use Disorder (16 Sep 2024)
- Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics (02 Sep 2024)
- Hormonal control of promoter activities of Cannabis sativa prenyltransferase 1 and 4 and salicylic acid mediated regulation of cannabinoid biosynthesis (29 Aug 2024)
- Molecular Insights into Epigenetics and Cannabinoid Receptors (27 Aug 2024)
- Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)